Tevogen Bio Holdings Inc (NASDAQ:TVGN) has a beta value of -1.31 and has seen 1.4 million shares traded in the last trading session. The company, currently valued at $176.78M, closed the last trade at $1.02 per share which meant it gained $0.02 on the day or 2.00% during that session. The TVGN stock price is -1967.65% off its 52-week high price of $21.09 and 74.51% above the 52-week low of $0.26. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.41 million shares traded. The 3-month trading volume is 16.38 million shares.

Tevogen Bio Holdings Inc (NASDAQ:TVGN) trade information

Sporting 2.00% in the green in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the TVGN stock price touched $1.02 or saw a rise of 7.27%. Year-to-date, Tevogen Bio Holdings Inc shares have moved -90.84%, while the 5-day performance has seen it change -4.67%. Over the past 30 days, the shares of Tevogen Bio Holdings Inc (NASDAQ:TVGN) have changed -31.08%. Short interest in the company has seen 3.69 million shares shorted with days to cover at 0.09.

Tevogen Bio Holdings Inc (TVGN) estimates and forecasts

The company’s shares have gained 17.24% over the past 6 months.

TVGN Dividends

Tevogen Bio Holdings Inc is expected to release its next earnings report in January this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Also the top two Mutual Funds that are holding company’s shares are Fidelity Small Cap Index Fund and iShares Russell 2000 Growth ETF . As of Aug 31, 2024 , the former fund manager holds about 0.12% shares in the company for having 207.17 shares of worth $0.21 million while later fund manager owns 146.24 shares of worth $0.15 million as of Sep 30, 2024 , which makes it owner of about 0.08% of company’s outstanding stock.